Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PCOR stock price vs IONS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IONS's multiple
Needs IONS P/S.
Implied fair value · at PCOR's multiple
Needs PCOR P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PCOR FY 2025 (ended Dec 31, 2025) · IONS FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Procore Technologies, Inc. · implied price per share
Bear
-$6.02
Base
-$7.08
Bull
-$8.14
Ionis Pharmaceuticals, Inc. · implied price per share
Bear
-$2.41
Base
-$2.83
Bull
-$3.26
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.68x
1.72x
Net debt / EBITDA
Leverage against operating earnings
-2.56x
5.71x
Cash and equivalents
Liquid reserves on the balance sheet
$768.49M
$2.68B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Autodesk, Inc.
PCOR vs ADSK
PTC INC.
PCOR vs PTC
ORACLE CORP
PCOR vs ORCL
Salesforce, Inc.
PCOR vs CRM
Workday, Inc.
PCOR vs WDAY
Sarepta Therapeutics, Inc.
PCOR vs SRPT
Moderna, Inc.
PCOR vs MRNA
Natera, Inc.
PCOR vs NTRA
ILLUMINA, INC.
PCOR vs ILMN
AMGEN INC
PCOR vs AMGN
VERTEX PHARMACEUTICALS INC / MA
PCOR vs VRTX
$855.22M
$839.57M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
